8:30 am Registration & Virtual Morning Coffee
Harnessing New Technology
9:00 am Chair’s Opening Address
9:10 am Optimizing R&D Costs with Machine Learning: How A Big Pharma Diagnoses & Improves Research Efficiency with AI-Assisted Reagent Selection
Synopsis
• Innovation driven by technology: how machine learning is optimizing reagent selection and reducing the burden of selection and validation. Initial situation and challenges
• Unlocking value with AI: Operational efficiencies, reducing search time, avoiding waste, accelerating science
• Transformation and expansion: how the positive results have led to into the project expansion and collaboration
9:30 am Case Study on Supplier Spend Analytics for Clinical Trials
9:50 am Live Q&A – Ask the Panel Your Burning Questions
10:10 am Buyer-Focused Private Marketplace Procurement: How Novel Solutions Are Shifting Power to Buyers While Aligning the Interests of Both Buyer & Supplier?
Synopsis
- Benefits, limitations and history of hosted catalogs, Level 1 and Level 2 punchouts
- Overview of new emerging models for procurement from new distributor models to marketplaces
- Evaluation of model maturity from a customer experience, analytics, pricing, and supplier management perspectives
- How new offerings are leveraging intelligent agents and powerful analytics to enhance the power of buyers and the effectiveness of suppliers
10:40 am Models, challenges and Triumphs of a Virtual Trial
Synopsis
- The benefits and lessons learned of virtual trials
- How to tackle patient buy-in and support virtual trials in order to expedite speed to market
11:00 am Live Q&A – Ask the Panel Your Burning Questions
11:20 am Speed Networking
11:45 am Coffee Break
Synopsis
• Visit Our Partners’ Booths in the Virtual Exhibition Hall
• 121 Meetings
12:00 pm Effects of Covid-19 on Procurement and Sourcing
Synopsis
• Global sourcing to manage supply chain risk with diminished supply
• Remote management of trials and studies
• Procurement of PPE for reopening of labs
12:45 pm Program Partner: LexisNexis
1:15 pm Networking Lunch
Strategic Sourcing
2:15 pm Strategic Sourcing for Rare Diseases & Emerging Therapeutics
Synopsis
• How to use in-sourcing as an effective strategy
• Key considerations when selecting a CMO in rare disease / gene therapy
2:35 pm Importance of Pre-Emptive Thinking in Procurement of NHP’s for Ultimate Product Approval
Synopsis
• As R&D continues to increase investment into large molecule drug products, safe, ethical and timely procurement of non-human primates has never been so important
• Challenges associated with R&D procurement for large molecule with respect to NHP’s, including predicting pricing, availability, lead time to sexual maturity and how to engage the market • How to overcome these challenges and minimize an often time-consuming barrier in getting to PoC human clinical trials
2:55 pm Technology Booms In Business Operations; A Case Study in RFP Automation
3:25 pm Live Q&A – Ask the Panel Your Burning Questions
3:55 pm Afternoon Tea
4:30 pm Proven Technology Driven Clinical Trial Supply Alternative
Synopsis
- Learn about an innovative and more efficient strategy that is changing the paradigm of clinical trial supply
- Understand how the alternative strategy saves time, money, mitigates risks and reduces clinical trial supply hassles
- Hear real-life case studies proving time and resource savings
- See how meeting the target “Study Start” and “First Patient In” date is more easily accomplished
4:45 pm Speaker Interview Followed by Debate: Single vs Dual vs TriSourcing – How Takeda Realigned their Sourcing Strategy Post Shire Acquisition
Synopsis
• Rinaldo Doorman (former Shire clinical category lead) interviews Wanlu Liu, Global lead Sourcing Manager, Takeda, on the organisational changes within Takeda post Shire acquisition
Debate: Post M&A: How to Re-Align and Ensure Smooth Integration
• With M&A on the rise we look at how to keep the best parts of both companies
• How to tackle “winner takes all” scenario and challenges with integration